Back

Continuous heart monitoring to evaluate treatment effects in pulmonary hypertension

30 August 2024 (08:00 - 17:30)
Organised by: Logo
Congress Presentation Part of: New physical insights into pulmonary vascular disease Pulmonary Hypertension ESC Professional Premium Access ESC Congress 2024 European Society of Cardiology

About the speaker

Photo
Mr Mads Oerbaek Andersen

Copenhagen University Hospital, Copenhagen (Denmark)

6 More presentations in this session

Presentation thumbnail
Echocardiographic insights redefining risk in pulmonary arterial hypertension: a focus on right atrial volume index for enhanced stratification
Doctor L. Brochado (Almada, PT)
Abstract Slides Video
Presentation thumbnail
Efficacy and safety of the Aria pulmonary endovascular device in pulmonary hypertension
Associate Professor C. Gerges (Vienna, AT)
Abstract Slides Video
Presentation thumbnail
May right heart failure cause pulmonary congestion in pulmonary arterial hypertension?
Professor M. D'Alto (Naples, IT)
Abstract Slides Video
Presentation thumbnail
Prognostic impact of the tricuspid annular plane systolic excursion/pulmonary arterial systolic pressure ratio in acute pulmonary embolism
Doctor B. Kultursay (Tunceli, TR)
Abstract Slides Video
Presentation thumbnail
Echocaridographic assessment of pulmonary hypertension: improving the probability
Mr C. Wild (Bath, GB)
Abstract Slides Video

Access the full session

Session thumbnail
New physical insights into pulmonary vascular disease

The Event

Event poster

ESC Congress 2024

30 August - 2 September 2024
You may be interested in
thumbnail
Congress Presentation
Remote monitoring program in patients with pulmonary hypertension: the French experience
thumbnail
Congress Presentation
Effects of beta blockers on outcome in patients with PAH with and without comorbid conditions: a Multicenter Prospective Cohort Study (BNP-PL).
thumbnail
Congress Presentation
Adults with congenital heart disease and pulmonary arterial hypertension: Quantitative assessment of haemodynamic parameters under disease targeting therapy - A retrospective multicentre analysis

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources